GSK (GSK.L) and Moderna (MRNA.O) settled patent infringement lawsuits on Friday covering Moderna’s COVID-19 vaccines Spikevax and mNEXSPIKE as well as its RSV shot mResvia, removing a significant legal overhang for both companies’ vaccine pipelines.
For long-horizon investors, the resolution...